Q/C TECHNOLOGIES, INC. - QCLS

Sector: Healthcare · Industry: In Vitro & In Vivo Diagnostic Substances
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$2.371M
QoQ value delta ($000)
-$626K (-20.89%)
Implied price effect (QoQ)
-12.51%
Shares
Total shares
680,627
QoQ shares delta
-72,098 (-9.58%)
Total shares held by funds (by quarter)

Market chart (QCLS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 18 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Quinn Opportunity Partners LLC 729 211,390 0.04%
JANE STREET GROUP, LLC 435 126,188 0.0%
UBS Group AG 269 77,989 0.0%
VANGUARD GROUP INC 211 53,066 0.0%
ADAR1 Capital Management, LLC 172 50,000 0.01%
GEODE CAPITAL MANAGEMENT, LLC 163 47,390 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 129 37,511 0.0%
HRT FINANCIAL LP 77 22,404 0.0%
DIMENSIONAL FUND ADVISORS LP 65 19,058 0.0%
VANGUARD FIDUCIARY TRUST CO 53 15,555 0.0%
STATE STREET CORP 44 12,905 0.0%
PIN OAK INVESTMENT ADVISORS INC 12 3,500 0.01%
Sunbelt Securities, Inc. 6 1,750 0.0%
Tower Research Capital LLC (TRC) 5 1,593 0.0%
BNP PARIBAS FINANCIAL MARKETS 1 300 0.0%
JONES FINANCIAL COMPANIES LLLP 0 2 0.0%
Wilmington Savings Fund Society, FSB 0 1 0.0%
ROYAL BANK OF CANADA 0 6 0.0%
BlackRock, Inc. 0 19 0.0%